Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab

Journal article

Open access

Peer reviewed

Eric K Chin, David R P Almeida and Elliott H Sohn

Canadian journal of ophthalmology, Vol.50(5), pp.e88-e91

10/2015

DOI: 10.1016/j.jcjo.2015.05.020

PMID: 26455990

Files and links (1)

url

https://doi.org/10.1016/j.jcjo.2015.05.020View

Published (Version of record) Open Access

Diabetic Retinopathy - drug therapy

Bevacizumab - therapeutic use

Intravitreal Injections

Diabetes Mellitus, Type 1 - physiopathology

Humans

Combined Modality Therapy

Diabetic Neuropathies - drug therapy

Laser Coagulation

Diabetic Retinopathy - surgery

Papilledema - therapy

Vascular Endothelial Growth Factor A - antagonists & inhibitors

Diabetic Retinopathy - therapy

Diabetic Neuropathies - surgery

Diabetic Retinopathy - physiopathology

Young Adult

Papilledema - physiopathology

Diabetic Neuropathies - therapy

Angiogenesis Inhibitors - therapeutic use

Female

Papilledema - surgery

Diabetic Neuropathies - physiopathology

Fluorescein Angiography

Papilledema - drug therapy

Title: Subtitle: Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab
Creators: Eric K Chin - University of Iowa, Iowa City, Iowa. Electronic address: chin.eric@gmail.com
David R P Almeida - University of Iowa, Iowa City, Iowa
Elliott H Sohn - University of Iowa, Iowa City, Iowa
Resource Type: Journal article
Publication Details: Canadian journal of ophthalmology, Vol.50(5), pp.e88-e91
Publisher: England
DOI: 10.1016/j.jcjo.2015.05.020
PMID: 26455990
ISSN: 0008-4182
eISSN: 1715-3360
Language: English
Date published: 10/2015
Academic Unit: Ophthalmology and Visual Sciences
Record Identifier: 9983979959902771

26 Record Views